ClinicalTrialsFinder

Renal Cell Cancer Metastatic Clinical Trials in Boston, Massachusetts

1 recruitingBoston, Massachusetts

Showing 1–1 of 1 trials

Recruiting
Phase 1

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

Triple-Negative Breast CancerColorectal, CancerBiliary Tract Cancer+8 more
Zumutor Biologics Inc.100 enrolled3 locationsNCT06451497